A detailed history of Cwm, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Cwm, LLC holds 900 shares of CYBN stock, worth $234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
900
Previous 900 -0.0%
Holding current value
$234
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$0.26 - $0.47 $225 - $408
-869 Reduced 49.12%
900 $0
Q2 2022

Jul 28, 2022

BUY
$0.41 - $0.88 $725 - $1,556
1,769 New
1,769 $1,000
Q1 2022

Apr 21, 2022

SELL
$0.74 - $1.22 $1,309 - $2,158
-1,769 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$1.13 - $2.31 $1,998 - $4,086
1,769 New
1,769 $2,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.